
Pilot and feasibility study: comparative proteomic analysis by 2-DE MALDI TOF/TOF MS reveals 14-3-3 proteins as putative biomarkers of response to neoadjuvant chemotherapy in ER-positive breast cancer
Keywords: شیمیدرمانی نئوادجوانت; BCS; breast conserving surgery; CR; chemotherapy resistant; CS; chemotherapy sensitive; DCE-MRI; dynamic contrast enhanced magnetic resonance imaging; DEP; differentially expressed protein; EC; epirubicin with cyclophosphamide; ER; oestrogen receptor; HER